Fisetin’s Anti-Inflammatory Mechanisms: What the Research Actually Shows
Fisetin targets NF-κB, MAPK, JAK/STAT, and other inflammatory pathways. Here is what preclinical evidence reveals—and where the human data stands.
Fisetin targets NF-κB, MAPK, JAK/STAT, and other inflammatory pathways. Here is what preclinical evidence reveals—and where the human data stands.
Fisetin shows neuroprotective potential in preclinical models relevant to Alzheimer’s disease. An honest look at what the research does—and does not—show.